Modification of growth related enzymatic pathways and apparent loss of tumorigenicity of a ras-transformed bovine endothelial cell line by treatment with 5-iodo-6-amino-1,2-benzopyrone (INH2BP)

International Journal of Oncology

Volumn 8, Issue 2, 1996, Pages 239-252

  Bauer, Pal I ^a  

^a SAN FRANCISCO STATE UNIVERSITY   (United States)

Author keywords

2 benzopyrone; 5 iodo 6 amino 1; Endothelial cell line; Ras gene

Indexed keywords

6 AMINO 5 IODO 1,3 BENZOPYRONE; BENZOPYRAN DERIVATIVE; DNA TOPOISOMERASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CARCINOGENICITY; CELL CULTURE; ENDOTHELIUM CELL; ENZYME ACTIVITY; GENE EXPRESSION; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; SOUTHERN BLOTTING;

EID: 0030030094     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.8.2.239     Document Type: Article

References (10)

1. Kun E, Kirsten E, Milo GE, Kurian P and Kumari HL: Cell cycle dependent intervention by benzamide of carcinogeninduced neoplastic transformation and in vitro polyADPrib'osylation of nuclear proteins in human fibroblasts. Proc Natl Acad Sci USA 80: 7219-7223, 1983.
2. Milo GE, Kurian P, Kirsten E and Kun E: Inhibition of carcinogen-induced cellular transformation of human fibroblasts by drugs that interact with the poly(ADP-ribose) polymerase system. FEBS Lett 179: 332-336, 1985.
3. Borek C, Morgan WF, Ong A and Cleaver JE: Inhibition of malignant transformation in vitro by inhibition of poly(ADPribose) synthesis. Proc Natl Acad Sci USA 81: 243-247, 1984.
4. Milo GE, D'Ambrosio S and Kun E: Benzamide prevention of UV-radiation induced transformation as measured by anchorage independent growth and absense of correlation with thymidine dimer formation and DNA repair. Mechanisms of chronic toxicity. Teratogenesis, Carcinog Mutagen 9: 167-176, 1989.
5. Tseng A Jr, Lee WFM, Kirsten E, Hakam A, McLick J, Buki K and Kun E: Prevention of tumorigenesis of oncogene-transformcd rat fibroblasts with DNA-site inhibitors of poly(ADP-ribose) polymerase. Proc Natl Acad Sci USA 84: 1107-1111, 1987.
6. Nagao M, Nakayasu M, Aonuma S, Shima H and Sugimura T: Loss of amplified genes by poly(ADP-ribose) polymerase inhibitors. Environ Health Perspect 93: 169-174, 1991.
7. Nakayasu M, Shima H, Aonuma S, Nakagama H, Nagao M and Sugimura T: Deletion of transfected oncogenes from NIH 3T3 transformants by inhibitors of poly(ADP-ribose) polymerase. Proc Natl Acad Sci USA 85: 9066-9070, 1988.
8. Hakam A, McLick J, Buki KG and Kun E: Catalytic activities of synthetic octadeoxyribonucleotides as coenzymes of poly (ADP-ribose) polymerase and the identification of a new enzyme inhibitory site. FEBS Lett 212: 73-78, 1987.
9. Kirsten E, Bauer PI and Kun E: Suppression of dexamethasone stimulated DNA synthesis in an oncogene construct containing rat cell line by a DNA-site oriented ligand of poly(ADP-ribose) polymerase. Exp Cell Res 193: 1-4, 1991.
10. Cole AG, Bauer G, Kirsten E, Mendeleyev J, Bauer PI, Buki KG, Hakam A and Kun E: Inhibition of HIV-1 IIIb replication in AA-2 cells in culture by two ligands of poly(ADP-ribose) polymerase: 6-amino-l, 2-benzopyrone and 5-iodo-6-amino-1, 2-benzopyrone. Biochem Biophys Res Commun 180: 504-514, 1991.